ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

Mid-Cap Stocks Stocks Under $10 Healthcare Stocks
$6.45
-0.08 (-1.23%)
As of Aug 8, 1:45 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +594.7% upside
Low Target $32.90
Average Target $44.81
High Target $56.58
Current Price $6.45
Current
$6.45
Target
$44.81
$32.90 $44.81 avg $56.58
Scenario Analysis
Bear Case
$32.90
410.1%
Low target
Base Case
$44.81
+594.7%
Avg target
Bull Case
$56.58
+777.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$8.44
-23.6% from high
52-Week Low
$2.75
+135.0% from low
50-Day SMA
$3.99
+61.7% vs SMA
RSI (14)
58.5
Neutral
Target vs 52W High
$44.81
+430.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 36 81% $369.21 -37.8%
DHR
Danaher Corp
 Strong Buy 32 84% $158.11 -22.8%
A
Agilent Technologies Inc
 Strong Buy 29 79% $64.69 -55.7%
WAT
Waters Corp
 Hold 30 53% $189.60 -53.4%
IQV
Iqvia Holdings Inc
 Strong Buy 29 76% $82.96 -65.2%
ILMN
Illumina Inc
 Buy 28 61% $169.36 -9.9%
MTD
Mettler-Toledo International
 Hold 20 50% $170.43 -88.1%
WST
West Pharmaceutical Services
 Strong Buy 22 91% $136.24 -61.5%